Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-0486 by AstraZeneca for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
AZD-0486 is under clinical development by AstraZeneca and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic...
AZD-0486 by AstraZeneca for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
AZD-0486 is under clinical development by AstraZeneca and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase...
AZD-0486 by AstraZeneca for Follicular Lymphoma: Likelihood of Approval
AZD-0486 is under clinical development by AstraZeneca and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase I...
AZD-0486 by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
AZD-0486 is under clinical development by AstraZeneca and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData,...